Vaccination in post-tuberculosis lung disease management: A review of the evidence

Mohammad Javad Nasiri; Denise Rossato Silva; Foad Rommasi; Mohammad Mahdi Zahmatkesh; Zohreh Tajabadi; Fatemeh Khelghati; Tala Sarmastzadeh; Rosella Centis; Lia D’Ambrosio; Sidney Bombarda; Margareth Pretti Dalcolmo; Tassiana Rodrigues dos Santos Galvão; Fernanda Carvalho de Queiroz Mello; Marcelo Fouad Rabahi; Emanuele Pontali; Ivan Solovič; Marina Tadolini; Lorenzo Marconi; Simon Tiberi; Martin van den Boom; Giovanni Sotgiu; Giovanni Battista Migliori

doi:10.1016/j.pulmoe.2023.07.002

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Vaccination deserves to be considered among the strategies to prevent and/or mitigate PTLD complications. Further evidence is necessary to better understand which vaccines have the greatest impact and cost-benefit.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nasiri et al. (2023) studied this question.

synapsesocial.com/papers/69dab51e00ab073a27838f77 https://doi.org/10.1016/j.pulmoe.2023.07.002

View Full Paper

Ask AI

Bookmark

Share

Vaccination in post-tuberculosis lung disease management: A review of the evidence

Ask about this paper

Abstract

Discussion

Cite This Study

Vaccination in post-tuberculosis lung disease management: A review of the evidence

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading